Introduction
Hypercoagulability is a significant complication of COVID-19 infection.
It can lead to life-threatening situations when hypercoagulability
manifests as clot burdens in vital organ systems. Keeping a low
threshold for suspecting and treating hypercoagulability induced
ischemia in vital organs is a crucial strategy to minimize the morbidity
and mortality associated with it. (1)
Early recognition of various uncommon presentations and complications of
COVID-19infection, subsequently leading to early management, is becoming
increasingly important in recent times. We present a case of COVID-19
induced hypercoagulability leading to ST elevation myocardial infarction
(STEMI) in a patient who developed cardiac failure ultimately requiring
left ventricular assist device (LVAD) implantation.